From the origin of NASH to the future of metabolic fatty liver disease.

Geier, Andreas; Tiniakos, Dina; Denk, Helmut; Trauner, Michael.

Afiliação

Geier A; Division of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg, Bayern, Germany Geier_A2@medizin.uni-wuerzburg.de.
Tiniakos D; Department of Pathology, Aretaieion Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece & Translational & Clinical Research Institute; Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Denk H; Institute of Pathology, Medical University of Graz, Graz, Steiermark, Austria.
Trauner M; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Wien, Wien, Austria.

Gut ; 2021 Feb 25.

Article em En | MEDLINE | ID: mdl-33632710